Ideas
Cheap Korean chip earnings can re-rate.
Semiconductors are among the earnings-linked leaders in January, with Samsung's preliminary results showing improving chip earnings. The foreign selling in Samsung and SK hynix looks more like rotation from expensive US big tech than a change in fundamentals, and Korean chip valuations remain cheap enough for re-rating as earnings improve.
Hyundai Motor tariff refunds lift earnings.
Hyundai Motor should benefit because most of the tariff cost was refunded except for one month in Q4 and the company is set to grow earnings this year. Korean autos have lagged US autos, and CES humanoid/valuation catalysts can support the catch-up; he also sees autos turning up versus Q3.
Defense demand structurally rising; must-own.
Defense demand is structurally rising because the US is stepping back from its world-police role and geopolitical risk is becoming routine; countries including Korea need cost-effective, proven weapons, and Korean defense companies have earnings momentum. He says defense cannot be excluded from a portfolio this year, though capacity and valuation mean the next leg may need the space angle.
US Navy new market to lift shipbuilders.
Korean shipbuilders need more than ordinary order momentum; the anticipated new market is US Navy/special vessels, with Arctic and naval issues adding to expectations. Korean shipbuilders are all trying to expand cooperation with the US, including Samsung Heavy, and because earnings provide a fundamental base, any opening of that market could drive a bigger step-up. The catalyst is expected but not yet open.
Korean equities relatively attractive versus US tech.
Korean equities look relatively attractive because earnings-linked sectors are cheap while US big tech carries valuation and price-gain burdens. Foreign investors may rotate from US big tech toward cheaper Korean earnings and value sectors, and even with noisy US geopolitics Korea can stay relatively strong; eventually the cheapest validated names should receive value re-rating.
Space can add defense valuation re-rating.
The additional defense angle he is watching is space: Korean defense firms already hold much of the relevant space technology, Korea has a roadmap to send a lunar orbiter and lander by 2032, and the target market is emerging countries rather than only the US. If space value and concrete volume attach to defense earnings, defense valuations could widen materially; for now he calls it a warming-up stage and says to revisit on pullbacks.
Humanoid theme gaining real substance.
Humanoid robotics has moved beyond an empty theme: Samsung has said it will focus on humanoids and cooperate with Nvidia, and Hyundai showed a humanoid at CES, giving the theme real substance. The move has spread beyond pure robot stocks, and although earnings are still limited, the market has a strong belief in future commercialization.
Doosan Enerbility earnings clearly improving.
He is cautious on calling the whole nuclear theme an earnings-surprise sector because it is broad and overlaps with construction, but specifically says Doosan Enerbility should show a clearly improving picture, making it the cleaner nuclear-linked earnings idea.
Samsung Biologics buy on plant momentum.
He made a fresh buy call on Samsung Biologics this week, the first since its early listing period in his telling. The thesis is that previously missing growth/factory momentum is becoming concrete: the GSK plant acquisition output has not been fully reflected, and potential 60th plant expansion or new construction news could add further momentum; he views it favorably on an annual basis.
Celltrion watch on new drug progress.
The Eli Lilly contract manufacturing deal is a real earnings driver because Lilly is handing over volume it previously produced, and a factory acquisition can provide additional upside. However, he is not yet convinced Celltrion can return to its old growth trend until new drug progress becomes concrete; valuation alone is not enough. He treats it as a watch on contract output, factory acquisition, and new drug data.
This 815 Money Talk (815머니톡) video, published January 09, 2026,
features Lee Young-hoon
discussing Korean semiconductor stocks, 005380.KS, Korean defense stocks, Korean Shipbuilding Stocks, Korean equities, Korean defense/space stocks, Korean humanoid robotics stocks, 034020.KS, 207940.KS, 068270.KS.
10 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Lee Young-hoon
· Tickers:
Korean semiconductor stocks,
005380.KS,
Korean defense stocks,
Korean Shipbuilding Stocks,
Korean equities,
Korean defense/space stocks,
Korean humanoid robotics stocks,
034020.KS,
207940.KS,
068270.KS
